ALTERITY THERAPEUTICS LTD (ATHE)
Data as of , from SEC Form 4 filings.
See up to 3 months of ATHE. The 7-day demo opens the 1M and 3M ranges and puts ATHE on your watchlist.
Start 7-day demoLatest ATHE insider trades
About ALTERITY THERAPEUTICS LTD (ATHE)
ALTERITY THERAPEUTICS LTD is an SEC registrant, filing under CIK 0001131343, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
ATHE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 142,860 | $71K |
ATHE insider transactions (Form 4)
54 Form 4 filings on record, the earliest from Jun 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter Ashley Marks - Director | Open-market purchase | Ordinary shares | 47,620 | $0.50 | $24K | |
| Peter Ashley Marks - Director | Open-market purchase | Listed option exp 31 Aug 2026 | 47,620 | $0.50 | $24K | |
| David Allen Stamler - Officer | Open-market purchase | Listed option exp 31 Aug 2026 | 47,620 | $0.50 | $24K | |
| Julian Michael Babarczy - Director | Grant or award | Unlisted option exp 15 Jun 2031 | 2,000,000 | $0.00 | - | |
| Lawrence Bernard Gozlan - Director | Grant or award | Listed option exp 15 Jun 2031 | 1,000,000 | $0.00 | - |
ATHE insider trading FAQ
What is the latest insider trade for ATHE?
ALTERITY THERAPEUTICS LTD (ATHE) had 2 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for ATHE runs to 4 Form 4 filings, the earliest from 2026-06-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ATHE stock?
3 insider purchases of ATHE were filed in the last 90 days, totaling $71K.
How many insiders are selling ATHE stock?
No insider sales of ATHE were filed in the last 90 days.
Where can I see ATHE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ATHE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
4The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Peter Ashley Marks view on EDGAR
- - David Allen Stamler view on EDGAR
- - Julian Michael Babarczy view on EDGAR
- - Lawrence Bernard Gozlan view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where ATHE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ATHE with a 7-day demo
- ATHE on your watchlist
- Every ATHE Form 4 filing on record
- Up to 3 months of ATHE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
